Ethical approval
This study has been approved by the ethical committees of the Kyoto Prefectural University of Medicine (RBMR-C-1249-4) and Ritsumeikan University (BKC-HM-2020-090). All experiments were performed according to the ethical principles for medical research outlined in the Declaration of Helsinki (1964) and its subsequent revisions (https://www.wma.net/). Informed consents were obtained from all patients before operation. Human nasal tissue samples (nasal polyp, uncinate process or inferior turbinate) were resected from patients who required surgery for chronic sinusitis and allergic rhinitis. Samples were immediately cooled and stored in cooled control solution (4°C) until cell isolation [9-11, 33].
Solutions and chemicals
The control solution contained (in mM) NaCl 121, KCl 4.5, NaHCO3 25, MgCl2 1, CaCl2 1.5, NaHEPES 5, HHEPES 5 and glucose 5. Its pH was adjusted to 7.4 by HCl (1 M) and the solution was aerated with 95% O2 and 5% CO2. The CO2/HCO3--free control solution was prepared by replacing NaHCO3 in the control solution with NaCl and was aerated with 100% O2. To apply the NH4+ pulse, NaCl (25 mM) of the control solution or the CO2/HCO3--free control solution were replaced with NH4Cl (25 mM). DNase I, amphotericin B, 4,4-Diisothiocyanatostilbene-2,2-disulfonic acid disodium salt hydrate (DIDS) and 2-chloro-N-[[2′-[(cyanoamino)sulfonyl][1,1′-biphenyl]-4-yl]methyl]-N- [(4-methylphenyl)methyl]-benzamide (S0859, a specifically selective inhibitor for NBC) were purchased from Sigma-Aldrich (St Louis, MO, USA). Dorzolamide and brinzolamide were purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Can Get Signal® Immunoreaction Enhancer Solution was purchased from TOYOBO (Osaka, Japan).
Cell culture media
Complete PneumaCultTM-Ex Plus medium contained PneumaCultTM-Ex Plus Basal Medium supplemented with PneumaCultTM-Ex supplement (50×, 20 µL/mL), hydrocortisone stock solution (1 µL/mL) and penicillin and streptomycin solution (10 µL/mL). Complete PneumaCultTM-ALI medium contained PneumaCultTM-ALI basal medium supplemented with PneumaCultTM-ALI supplement (10×, 100 µL/mL), PneumaCltTM-ALI maintenance supplement (10 µL/mL), heparin solution (2 µL/mL), hydrocortisone stock solution (2.5 µL/mL) and penicillin/streptomycin solution (10 µL/mL). Solutions and supplements were purchased from STEMCELL Technologies, INC. (Vancouver, BC, Canada). Elastase, bovine serum albumin (BSA) and dimethyl sulfoxide (DMSO) were purchased from FUJIFILM Wako Pure Chemical Corporation. (Osaka, Japan). Penicillin/streptomycin mixed solution (penicillin 10000 units/mL and streptomycin 10000 µg/mL in 0.85% NaCl), trypsin, and the trypsin inhibitor were purchased from Nacalai Tesque, Inc. (Kyoto, Japan).
Antibodies
The anti-CAIV antibody (MAB2186, mouse antibody directed against recombinant human CAIV (rhCA4; aa 19-283)) was purchased from R&D Systems (Minneapolis, MN, USA). The concentration of MAB2186 used was 25 µg/mL. The antigen peptide (2186-CA, recombinant human CAIV) was also purchased from R&D systems. The anti-alphatubulin (acetyl K40) (AC-tubulin) antibody (ab179484) was purchased from Abcam and used at a 100-fold dilution. Alexa Fluor 488 goat anti-mouse IgG (H+L) secondary antibodies (A-11001) and Alexa Fluor 594 donkey anti-rabbit IgG (H+L) secondary antibodies (A-21207) were purchased from Thermo Fischer Scientific (Waltham, MA, USA).
Cell preparation
We isolated c-hNECs from nasal operation samples as described previously [9-11, 33]. Briefly, resected samples were cut into small pieces and incubated for 40 min at 37°C in control solution containing elastase (0.02 mg/mL), DNase I (0.02 mg/mL) and BSA (3%). Then, the samples were minced in control solution containing DNase I (0.02 mg/mL) and BSA (3%) using fine forceps. Isolated nasal cells were washed with control solution containing BSA (3%) three times with centrifugation at 160 × g for 5 min and then sterilised for 15 min using amphotericin B (0.25 μg/mL) in Ham’s F-12 with L-glutamine. Isolated nasal epithelial cells were cultured in complete PneumaCult-Ex medium in a collagen-coated flask (Corning, 25cm2, NY 14831 USA) at 37°C in a humidified 5% CO2 atmosphere. The medium was changed every second day. Once the cells reached confluency, they were washed with PBS (5 mL) and harvested in Hank’s balanced salt solution (HBSS, 2 mL) containing 0.1 mM EGTA and 0.025% trypsin to remove cells from the flask. Then, a trypsin inhibitor was added into the cell suspension to stop further digestion. After washing with centrifugation, cells were resuspended in complete PneumaCultTM-Ex Plus medium (1–2 × 105 cells, 3mL) and seeded on a filter of Transwell permeable supports insert (Coster 3470, 6.5 mm Transwell with 0.4 μm Pore Polyester Membrane Inserts, Corning) (3.0 ×104 cells/insert, 400 μL). Complete PneumaCultTM-Ex Plus medium was added into the upper and bottom chambers and cells were cultured until confluent. Then, the medium in the bottom chamber was replaced with complete PneumaCultTM-ALI medium (500 μL) and the medium in the upper chamber was removed to expose cells to the air (ALI culture). The medium in the bottom chamber was changed thrice a week. Cells were cultured for 3 weeks under the ALI condition to allow differentiation into ciliated cells (Inui et al., 2019).
NHBE cells were purchased from Lonza (Basel, Switzerland) and cultured in the flask, in which complete PneumaCultTM-Ex Plus medium was added at 37°C in a humidified 5% CO2 atmosphere. Once the cells had reached confluency, they were washed with PBS (5 mL) and harvested with HBSS (2 mL) containing 0.1 mM EGTA and 0.025% trypsin. Then, a tripsin inhibitor was added. After washing cells with centrifugation, cells were resuspended in complete PneumaCultTM-Ex Plus medium (3 mL). The cells were seeded onto the filter of Transwell permeable supports inserts (3.0 ×104 cells/insert, 400 μL) and cultured into complete PneumaCultTM-Ex Plus medium, which was also added to the upper and bottom chambers. Once the cells reached confluency, the medium in the bottom chamber was replaced with PneumaCultTM-ALI medium (500 μL) and the medium in the upper chamber was removed (ALI culture). The medium in the bottom chamber was changed thrice a week. Cells were cultured for 3 weeks under the ALI condition [20]. There were no differences in the development of cilia between nasal epithelial and NHBE cells.
Measurements of CBF and CBD
The insert membrane filter on which cells had grown was cut into 4–6 pieces. A piece of membrane was placed on a coverslip precoated with neutralised Cell-Tak (Becton Dickinson Labware, Bedford, MA, USA). The coverslip with cells was then set in a perfusion chamber (20 µL), which was mounted on an inverted microscope (T-2000, NIKON, Tokyo, Japan) connected to a high-speed camera (IDP-Express R2000, Photron Ltd., Tokyo) (high-speed video microscope). The cells were perfused at a constant rate (200 µL/min). Since CBF is sensitive to temperature, the experiments were carried out at 37°C [4, 9-11]. Video images were recorded for 2 s at 500 fps. The methods to measure CBF and ciliary bend distance (CBD, an index of ciliary beating amplitude) have been described in detail [9-11, 33]. The ratios of CBF (CBFt/CBF0) and CBD (CBDt/CBD0) were calculated to make comparisons across the experiments. The subscripts ‘0’ and ‘t’ indicate the time from the start of the experiments.
Measurement of pHi
The cell sheet was removed from the insert membrane filter using an EGTA treatment (incubation with a Ca2+-free control solution containing 1 mM EGTA (pH 7.2)) for 10 min at room temperature. Then, the cell sheet was incubated with 2 µM BCECF-AM (Dojindo Laboratories, Kumamoto, Japan) for 30 min at 37°C. After BCECF loading, the cell sheet was cut into small pieces (4–6 pieces). A piece was set in a perfusion chamber and the fluorescence of BCECF was measured using an image analysis system (MetaFluor, Molecular Device, USA). BCECF was excited at 440 nm and 490 nm and the emission was recorded at 530 nm. The fluorescence ratio (F490/F440) was measured at 37°C using the image analysis system. The calibration curve for pHi was obtained using BCECF-loaded cells perfused with a calibration solution containing nigericin (15 µM, Sigma-Aldrich, St Louis, MO, USA) and having a pH adjusted to 6.5, 7.0, 7.5, or 8.0. The calibration solutions contained (in mM): KCl 150.5, MgCl2 2, CaCl2 1, HEPES 10 and glucose 5.
RT-PCR
Total RNA samples from c-hNECs (obtained from operation samples) and c-hBECs (derived from NHBE cells) were prepared using RNeasy Minikit (QIAGEN, Tokyo, Japan). Total RNA was reverse-transcribed to cDNA using an oligo d(T)6 primer and an Omniscript RT kit (QIAGEN). Then, cDNA samples were subjected to Reverse transcription-polimerase chain reaction (RT-PCR) using KOD FX (TOYOBO). The gene-specific primers are listed in Table 1 for human CA and Table 2 for human NBC and anion exchangers (AE). The amplified PCR products were confirmed using agarose.
(Table 1 and Table 2)
Western blot analysis
Cells on the insert membrane filter were washed with PBS and separated from the filter. Then, cells were homogenised using radioimmunoprecipitation assay buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Nonidet-P40, 0.5 % sodium deoxycholate and 0.1 % SDS, pH 7.6) containing a protease inhibitor cocktail and incubated at 4°C for 20 min. Cells were then centrifuged at 16,000 × g for 20 min at 4°C. The supernatant was used as cell lysate. Proteins were separated using Laemmli’s SDS-polyacrylamide gel electrophoresis (8%–12.5%) and then transferred onto a polyvinylidene difluoride membrane. The membrane was blocked with milk (2.5%) in Tris-buffered saline (10 mM Tris-HCl and 150 mM NaCl, pH 8.5) containing 0.1% Tween 20 (TBST) for 1 h and then incubated with a primary antibody (MAB2186, R&D System) diluted in solution 1 (Can Get Signal Immunoreaction Enhancer Solution, TOYOBO) overnight at 4°C. After washing with TBST, the membrane was incubated with a secondary antibody (AP124P, anti-mouse IgG) diluted in solution 2 (Can Get Signal Immunoreaction Enhancer Solution, TOYOBO) for 1 h at room temperature. After washing, antigen–antibody complexes on the membrane were visualised using a chemiluminescence system (ECL plus; GE Healthcare, Waukesha, WI, USA).
Immunofluorescence examination
Immunofluorescence examinations were performed in c-hNECs and c-hBECs [21]. Cells on the Transwell insert membrane filter were removed using a cell scraper and suspended in PBS (2 mL). The cell suspension (0.5 mL) was dropped and dried on the cover slip, to which cells attached. Then, cells were fixed in 4% paraformaldehyde for 30 min and washed three times with PBS containing 10 mM glycine. Cells were permeabilised with 0.1% Triton X-100 for 15 min at room temperature. After 60 min pre-incubation with PBS containing 3% BSA at room temperature, cells were incubated with the anti-CAIV (MAB2186) and anti- AC-tubulin (ab179484, Abcam) antibodies overnight at 4°C. Then, cells were washes with PBS containing 0.1% BSA to remove unbound antibodies. Afterwards, cells were stained with Alexa Fluor 488 goat anti-mouse IgG (H+L) (A-11001, 1:100 dilution) and Alexa Fluor 594 donkey anti-rabbit IgG (H+L) (A-21207, 1:100 dilution) secondary antibodies for 60 min at room temperature. Cells were observed using a confocal microscope (FV10i, Olympus, Tokyo) [21].
Statistical analysis
Statistical significance was assessed using one-way analysis of variance or Student’s t-test (paired or unpaired), as appropriate. Differences were considered significant for p-values < 0.05. The results are expressed as the means ± SD.